Breast cancer strikes one of eight women in Switzerland. A woman's risk to get breast cancer is linked to her reproductive history. While early pregnancies have a protective effect, cancer risk increases with the number of menstrual cycles a woman experiences prior to her first pregnancy. Although it is well established that the female sex hormones oestrogen, progesterone and prolactin control breast development and have an important role in breast carcinogenesis, the mechanisms by which they exert their effects are poorly understood.
Prof. Brisken and her 15-strong research team are dedicated to studying how the female sex hormones (oestrogen, progesterone and prolactin) exert their effects. Their goal is to understand the roles these hormones play in breast development and breast cancer. |
Dr. Cathrin Brisken is a leading scientist from the Swiss Institute for Experimental Cancer Research at EPFL. She shared her research on understanding the roles that hormones play in breast development and breast cancer. Prof. Brisken and her 15-strong research team are dedicated to studying how the female sex hormones (oestrogen, progesterone and prolactin) exert their effects. The end goal is to understand the roles these hormones play in breast development and breast cancer. She also studies the effect of environmental factors in the development of breast cancer.
See more on Dr. Brisken here |